How Do Pharmaceutical Companies Design the Medicines We Use

Summary

Profile

Financials

Events

Ownership

Options

Competitors

Symbol	Last	Change

Learn to Trade Like a Pro

Master The Market with the Help of Our Financial Experts

SUBSCRIBE NOW

LATEST NEWS

Dow, S&P 500 and Nasdaq End at Record Highs on Trade-Deal Hopes, Merger Activity

MARKETS

UBEREBAYMDCO

Dow, S&P 500 and Nasdaq End at Record Highs on Trade-Deal Hopes, Merger Activity

By Rob Lenihan

Nov 25, 2019 4:16 PM EST

Latest News

Novartis Reaches $9.7 Billion Deal to Buy Cholesterol Drug Maker Medicines Co.

Nov 25, 2019 9:35 AM EST

Tiffany, Schwab, Novartis, 'Frozen 2,' Jerome Powell - 5 Things You Must Know

Nov 25, 2019 7:06 AM EST

Dow Futures Slide, Global Stocks Sputter as Trump Renews China Tariff Threat

Dow Futures Extend Gains, Global Stocks Bounce as Trade Optimism Lifts Sentiment

Nov 25, 2019 6:19 AM EST

Novartis to Swallow Up The Medicines Company for $9.7 Billion

Nov 24, 2019 5:10 PM EST

Novartis Reportedly Close to Buying Medicines Co.

Nov 24, 2019 8:13 AM EST

Shares of CRISPR Therapeutics Fall in After Hours Trading on Share Offering

Nov 19, 2019 8:37 PM EST

Nasdaq Closes at Record High, Stocks Mixed Over Home Depot, Trump Trade Threat

Nov 19, 2019 4:25 PM EST

Medicines Co. Surges After Cholesterol Drug Maker Linked to Novartis Takeover

Nov 19, 2019 9:38 AM EST

Home Depot, Kohl's, Boeing, Salesforce, Medicines Co. - 5 Things You Must Know

Nov 19, 2019 7:20 AM EST

Medicines Co. Jumps on Pair of Bullish Notes

Sep 25, 2019 11:28 AM EDT

Good Job Growth, Low Inflation: Cramer's 'Mad Money' Recap (Friday 6/1/18)

Medicines Co. Rises on Positive Phase 3 Trial for Cholesterol Lowering Therapy

Aug 26, 2019 1:42 PM EDT

Atlassian, AeroVironment, Granite Construction: 'Mad Money' Lightning Round

Feb 7, 2018 6:27 AM EST

The Bottom? Not So Fast: Cramer's 'Mad Money' Recap (Tuesday 2/6/18)

Feb 7, 2018 6:21 AM EST

Fight Off Complacency: Cramer's 'Mad Money' Recap

Sep 16, 2017 6:44 AM EDT

Mesoblast Soars on Stem-Cell Treatment Data

Otonomy Shares Fall On Disappointing Phase 3 Data - Biotech Movers

Aug 30, 2017 9:46 AM EDT

Why Alexion's Gain In the C-Suite Doesn't Bode Well For Biogen Takeout Prospects

Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite

Jul 25, 2017 12:35 PM EDT

Rite Aid Stock Jumps Following Earnings Beat

How to Trade the Week's Most Active Stocks - Rite Aid, Amgen, MuleSoft and More

Mar 17, 2017 7:15 PM EDT

AveXis, Esperion and Amgen Among Biotech Movers

Mar 17, 2017 11:03 AM EDT

Biotech premarket movers: Ardelyx, Acorda Therapeutics, Medicines Co.

Feb 15, 2017 9:27 AM EST

Premarket biotech movers: Portola, Esperion, Medicines

Feb 3, 2017 9:32 AM EST

Amgen shares skyrocket on surprise patent victory

Jan 6, 2017 10:13 AM EST

Medtronic Earnings Rebound in Third Quarter, Shares Climb

5 stocks insiders love right now

Dec 15, 2016 2:12 PM EST

Alder BioPharmaceuticals: Cramer's Top Takeaways

Why medicines co. (mdco) stock is falling today

Oct 6, 2016 1:04 PM EDT

3 Leisure Stocks Pushing Industry Growth

Barbarian At The Gate: Medicines (MDCO)

Jul 11, 2016 10:25 AM EDT

Recent Articles from TheStreet

INVESTING

U.S. Government Is a Bitcoin Seller: $8.5 Billion Worth

The U.S. seizes bitcoins from bad guys and then unloads them. It has dumped 185,000 bitcoins since it began confiscating them.

INVESTING

DRI

Olive Garden Parent Darden Still a Buy at 2 Firms - With Covid Caveat

Analysts at Keybanc and Credit Suisse remained bullish about Darden's outlook while noting that rising infections and inflation could hurt its valuation.

Student Loans at $1.3 Trillion Shove Family Debt Toward Pre-Crisis Peak

INVESTING

NAVI

Navient Adopts Poison Pill in Light of Sherborne Stake

Sherborne has reportedly built a 16% stake in the company, making it the largest shareholder.

INVESTING

BMOBNPQY

BMO Agrees to Buy BNP's Bank of the West for $16 Billion

Bank of the West conducts all of BNP Paribas' retail and commercial-banking business in the U.S.

INVESTING

Candy-Cane Supply Reportedly Unable to Keep Up With Demand

Candy canes are getting hooked up by supply chain headaches and a drop in peppermint production.

Jim Cramer: I've Liked Six Flags Entertainment Stock as an Income Producer

INVESTING

SIXWHHLT

Six Flags, Wyndham, Hilton Touted at Goldman on Reopening Trade

Given the correction in gaming, lodging and leisure stocks over the past month, Goldman sees potential for the reopening trade.

Tencent Says It Has The Technology To Build The Metaverse And Beijing Does Not Oppose The Concept

INVESTING

FBSNAPRBLX

Goldman Sees Meta Platforms, SNAP as Metaverse Winners

Meta Platforms has 'leading scale within the digital advertising industry and market-leading innovation,' Goldman analysts say in a new research report.